top of page
gelber Button_neu.png

THE 

BIOMATERIAL,

PAIN FREE, 

AND PRECISE 

TISSUE MARKER

gelber Button_neu.png

OUR VISION

In 2023 our SchurSign® product will be available to women in the US diagnosed with suspicious lesions in their breast. Because of SchurSign®‘s unique biomaterial characteristics, doctors will be able to provide their patients with less invasive, much more gentle, and equally successful treatment.

Dienstleistungen
Kontakt
gelber Button_neu.png

         Ultrasound 

visible, metal-free 

marking – an unmet need in breast cancer

          A company specializing in innovative solutions in medical technology and biotechnology

gelber Button_neu.png

        News about the product, production, launch and our team

gelber Button_neu.png
gelber Button_neu.png

Breast cancer is big and growing due to higher life expectancy, systematic diagnostic and screening, but also due to environmental effects in younger women.

gelber Button_neu.png

The earlier it is found, the better the chance for a non-radical therapy, such as total breast amputation.

gelber Button_neu.png

Non-radical or minimally invasive therapies require better ultrasound visibility of markers. Current markers are a provisional solution at best.

gelber Button_neu.png

Current markers are a provisional solution at best.

istockphoto-184698209-1024x1024_web.jpg

That’s why women and their doctors need SchurSign®.

SchurSign® 

– a sure sign!

bottom of page